Tag

Mr. Nangavaram Mahadevan Ranganathan

1 article

Indrayani Biotech Q1 FY27 Net Profit ₹14.50 Lakhs

Board approved unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026). Standalone Q1 revenue was ₹415.34 lakhs with net profit of ₹14.50 lakhs and EPS of ₹0.